Skip to main content

COMMERCE BANK

Bank

Position in NVS — Novartis AG

CIK 1009076 KANSAS CITY, MO

Position in NVS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,930,567
+$37,985 QoQ
Shares Held
31,461
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#264
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 92% Shared 4% None 4%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

COMMERCE BANK holds $977,076,250 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,930,567 31,461
2026-03-31 $4,892,582 32,030
2025-12-31 $3,116,413 22,604
2025-09-30 $2,839,617 22,143
2025-06-30 $2,636,202 21,785
2025-03-31 $2,654,672 23,813
2024-12-31 $2,066,085 21,232
2024-09-30 $2,488,687 21,637
2024-06-30 $2,294,744 21,555
2024-03-31 $2,100,200 21,712
2023-12-31 $2,254,255 22,326
2023-09-30 $2,274,736 22,332
2023-06-30 $2,222,542 22,025
2023-03-31 $2,067,976 22,478
2022-12-31 $2,036,118 22,444
2022-09-30 $1,786,538 23,504
2022-06-30 $1,898,036 22,454
2022-03-31 $1,951,910 22,244
2021-12-31 $2,000,700 22,873
2021-09-30 $2,024,545 24,756
2021-06-30 $2,367,220 25,945
2021-03-31 $2,209,657 25,850
2020-12-31 $2,360,182 24,994
2020-09-30 $2,182,956 25,103
2020-06-30 $3,073,581 35,191
2020-03-31 $1,952,168 23,677